top of page

OCI-AML-3 Xenograft Model

Rincon Bio offers efficacy studies using the OCI-AML-3 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Blood
Derivation:
57yo male
Mutations:
DNMT3A, NRAS, NPM1
NCI60:
No
Weeks from stratification to termination (average):
2

OCI-AML-3 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the OCI-AML-3 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

All Xenograft Models

All Syngeneic Models

bottom of page